New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management

May 2005

New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management.

All Rx NSAIDs will carry a new boxed warning about GI and cardiovascular risk. You'll have to dispense a new Med Guide.

Celebrex (celecoxib) will also have a Medication Guide and boxed warning...plus clinical trial data on cardiovascular risk.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether physicians can write multiple C-II Rxs on the same day, for the same patient, for the same drug
Alzheimer's Disease Janssen is changing the name of Reminyl to Razadyne
Pediatrics new Children's Tylenol Meltaways an accident waiting to happen
Neurology & Pain certain generic versions of Duragesic don't seem to work as well
Neurology & Pain New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management
Antithrombotics prescribing 1300 mg/day of aspirin to prevent recurrent stroke
Antithrombotics patients are caught by surprise when fad diets or special foods interfere with their warfarin therapy
Infectious Diseases Baraclude (entecavir), a new oral antiviral for chronic hepatitis B
Infectious Diseases new IV antifungal, Mycamine (micafungin)
Boniva (ibandronate), the new once-MONTHLY bisphosphonate for osteoporosis
new warnings that bisphosphonates may cause death of bone tissue in the jaw
Thyroid Disorders Should patients with hypothyroidism be treated with both levothyroxine (Synthroid, etc) AND liothyronine (Cytomel)?
Women's Health new form of Depo-Provera called Depo-subQ Provera 104
Women's Health New rumors suggest that Plan B is going OTC